Rata, Mihaela
Khan, Khurum
Collins, David J
Koh, Dow-Mu
Tunariu, Nina
Bali, Maria Antonietta
d’Arcy, James
Winfield, Jessica M
Picchia, Simona
Valeri, Nicola
Chau, Ian
Cunningham, David
Fassan, Matteo
Leach, Martin O
Orton, Matthew R
Funding for this research was provided by:
cancer research uk (C1060/A10334, C1060/A16464)
Article History
Received: 4 August 2021
Accepted: 24 November 2021
First Online: 19 December 2021
Declarations
:
: The trial recruitment was approved by our institutional review board (National Research Ethics Service, NRES Committee London-Fulham; Research Ethics Committee reference 14/LO/1812) and informed written consent was obtained from each patient.
: Not applicable (only anonymised images are included and no individual details are included in the publication).
: MF received honoraria for consulting, advisory role, speaker bureau, and/or research funding from Astellas Pharma, QED Therapeutics, Diaceutics, Tesaro, Roche, Eli Lilly and Novartis.NV received honoraria from Merck Serono, Pfizer, Bayer and Eli-Lilly.DCum received honoraria from Bayer.The remaining authors of this manuscript declare that they have no competing interests.